Vetter Packaging Solutions

Opportunities for contract development and manufacturing organisations (CDMOs) in China continue to grow but many questions remain over what the future of the sector will look like in the world's second largest pharmaceutical market.

As experienced partner in injectable manufacturing, we support you every step of the way, guiding your product through development, regulatory approval, launch, market supply and life cycle management, accelerating your ability to bring new drugs to market

The strategic move will enable the injectables CDMO to support domestic companies that plan on bringing their molecules to the global market

We look at your project from every angle to help you find answers that work – answers that support your goals for quality, reliability, innovation, safety, and efficiency. When you partner with us, we integrate with your team to design and implement a personalized plan for success in a shifting global marketplace.

The CDMO responds to the growing demand for complex fill and finish solutions.

Judges describe the CDMO's "exemplary management" as a role model for other medium-sized companies.

Delivering results across the production chain

A win in all six core categories reaffirms Vetter as a trusted solution provider.

From clinical development to commercial production

Bundling of competencies optimizes workflow of customer projects.

Supporting your compounds success

Vetter has increased development capacity by bringing all its laboratories together into its 1,800 square metre Ravensburg site in Germany, the contract manufacturing and development organisation (CDMO) said Thursday.

We offer a wide range of packaging services and injectable delivery systems that can be tailored to your product’s specific needs and optimize end-user convenience.

Vetter increasingly relies on close interaction of humans and machines for greater flexibility.

This innovative concept is based on the central idea of fully automated decontamination of the entire cleanroom, including RABS, using hydrogen peroxide (H2O2). V-CRT®️ is a two-barrier system that minimizes the risk of contamination and offers a number of advantages over existing concepts.

Company voted one of Chicago’s Best and Brightest companies to work for.

The increasing demand for the manufacturing of highly complex biologics has driven many biotech and pharma companies to seek alliances with CDMOs. A qualified CDMO can help to understand business priorities, develop strategies to save time and costs, and provide regulatory guidance. This, in turn, means that CDMOs must have the right approach in place to fulfil high-quality requirements and have the right manufacturing technologies and capabilities in place. The complexity of CDMOs’ work will increase with new markets, demographic changes, and new demands in the clinical production of pharmaceuticals. This podcast was originally aired as part of the CPhI Festival of Pharma.

All German sites of the pharmaceutical service provider will be supplied with green electricity.

Expansions will help meet an increase in customer projects; a second extension is in the final planning stage.

Pharmaceutical service provider relies on expanded capacities, modular production and modern analytics.